rolipram has been researched along with Liver Dysfunction in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Rolipram is a specific type IV phosphodiesterase inhibitor that suppresses the activity of immune cells and the production of pro-inflammatory cytokines." | 1.33 | Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats. ( Hatakeyama, N; Horikawa, Y; Jin, M; Komatsu, K; Konishi, N; Matsuhashi, T; Odashima, M; Ohba, R; Otaka, M; Oyake, J; Sato, T; Wada, I; Watanabe, S, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsuhashi, T | 1 |
Otaka, M | 1 |
Odashima, M | 1 |
Jin, M | 1 |
Komatsu, K | 1 |
Konishi, N | 1 |
Wada, I | 1 |
Sato, T | 1 |
Horikawa, Y | 1 |
Ohba, R | 1 |
Oyake, J | 1 |
Hatakeyama, N | 1 |
Watanabe, S | 1 |
1 other study available for rolipram and Liver Dysfunction
Article | Year |
---|---|
Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Liver Diseases; Male; Phosphodiesterase Inhibitors; | 2005 |